In June, the Department of Veterans Affairs chose to approve the use of a new, expensive antidepressant despite concerns about the drug’s effects and speculation about the president’s involvement.
Veterans Affairs Approves ‘Ketamine-Like’ Drug Despite Cost, Doctors’ Misgivings
